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The ability to selectively target specific biofilm species with antimicrobials would enable control over biofilm
consortium composition, with medical applications in treatment of infections on mucosal surfaces that are
colonized by a mixture of beneficial and pathogenic microorganisms. We functionalized a genetically engi-
neered multimeric protein with both a targeting moiety (biotin) and either a fluorophore or a photosensitizer
(SnCe6). Biofilm microcolonies of Aggregatibacter actinomycetemcomitans, a periodontal pathogen, were targeted
with the multifunctional dodecamer. Streptavidin was used to couple biotinylated dodecamer to a biotinylated
anti-A. actinomycetemcomitans antibody. This modular targeting approach enabled us to increase the loading
of photosensitizer onto the cells by a cycle of amplification. Scanning laser confocal microscopy was used to
characterize transport of fluorescently tagged dodecamer into the microcolonies and targeting of the cells with
biotin-labeled, fluorescently tagged dodecamer. Light-induced activity of the targeted photosensitizer reduced
the viability of A. actinomycetemcomitans biofilm, as indicated by membrane permeability to propidium iodide.
The functionalized multimeric protein promises to be a useful tool for controlling periodontal biofilm consortia
and offers a modular design whereby moieties that target different species can be readily combined with the
functionalized protein construct.
Therapeutic tools that enabled targeted delivery of antimi-
crobials to specific species in biofilms would expand our capa-
bility to treat chronic infections associated with mucosal sur-
faces where complete sterility is not the natural healthy
condition. The oral cavity and the gut are prime examples of
mucosal surfaces at which the immune system maintains a
healthy microbial presence (3, 50). Mucosal surfaces in the oral
cavity are nonsterile environments colonized by biofilm con-
sortia (38). In the gut, some commensals are true symbionts
(30, 36), and similarly, it is hypothesized that oral commensals
may aid in maintaining a healthy immune homeostasis (35).
The implication is that treatment of oral diseases such as peri-
odontal disease can be made more effective by selective elim-
ination of pathogens. By extension, we may also find that tools
that enable specific targeting of biofilm pathogens provide
effective treatments for chronic infections of the gut (31).
A class of multimeric proteins that self-assemble into highly
symmetric quaternary structures (7, 52) shows promise for
development into delivery vehicles for therapeutic (15, 16, 44)
and imaging agents (41, 51). We selected one of these proteins,
a relatively small, spherical, 9-nm-diameter dodecamer, origi-
nally isolated from Listeria inocula (LiDps) (21), for targeted
delivery of a photosensitizer to Aggregatibacter actinomycetem-
comitans biofilm. We genetically added a tetrapeptide to the C
terminus of each of the 12 monomeric 18-kDa subunits of
LiDps. Cysteines incorporated into this tetrapeptide were la-
beled with biotin. Since the C terminus is presented on the
exterior surface of the assembled dodecamer, these biotins
were readily available for binding to streptavidin, a universal
coupling protein. An SnCe6 photosensitizer was covalently
linked to intrinsic lysines.
Photosensitizers are compounds that produce reactive oxy-
gen species (ROS) upon excitation by light (25). Antimicrobial
photodynamic therapy (PDT) has been shown to be effective
against oral pathogens (6, 29, 54). SnCe6 has been used pre-
viously for targeted antimicrobial PDT (10–12). The primary
modes of action of photosensitizers are membrane disruption
and, if the photosensitizer is internalized, DNA damage (19).
The antimicrobial activity of ROS produced by light-activated
photosensitizers is relatively localized. This is especially the
case for singlet oxygen (diffusion length of 50 nm), which is
thought to be the primary ROS causing cell death (32). The
localized action of photosensitizers makes them attractive
agents for targeted antimicrobial therapy.
The LiDps genetic construct, dual functionalized with
SnCe6 and biotin, is a modular unit that can be combined with
any targeting moiety that can be biotinylated. This would ac-
commodate a variety of approaches that have been used to
target microbial pathogens, including lectin/carbohydrate in-
teractions (53), antimicrobial peptides (8, 22), and the lysins
isolated from bacteriophage (14). We chose to use an antibody
as the targeting moiety for these studies since monoclonal
antibodies are available for a number of the prevalent peri-
odontal pathogens (5, 9, 17). In addition, antibodies offer a
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wide range of potential cell surface targets combined with the
possibility to engineer high binding affinities (4).
A. actinomycetemcomitans is a Gram-negative periodontal
pathogen implicated as the primary etiological agent in local-
ized aggressive periodontitis (13, 37). Rough colony variants
isolated from sites of infection form discrete microcolonies
when cultured in vitro which exhibit distinctive cohesive as well
as adhesive properties (27). We characterized transport of the
LiDps dodecamer to the base of A. actinomycetemcomitans
microcolonies, demonstrated targeting of the LiDps to the
cells in the microcolonies, and showed that SnCe6 targeted to
24-h biofilms produced light-activated membrane disruption.
The modular design enabled us to use cycles of alternating
exposure to the streptavidin and the LiDps dodecamer to in-
crease the loading of targeted photosensitizer onto the cells.
MATERIALS AND METHODS
Bacterial strain and culture conditions. Aggregatibacter actinomycetemcomi-
tans (formerly Actinobacillus actinomycetemcomitans) strain D7, a rough colony
clinical isolate obtained from the central incisor of an African-American female
patient with generalized aggressive periodontitis, was provided by Casey Chen,
University of Southern California. The liquid medium was modified tryptic soy
broth (MTSB) consisting of (per liter) 30 g tryptic soy broth and 3 g yeast extract.
The solid medium was MTSB with 50 ml fetal bovine serum (HyClone) and 15 g
Bacto agar added (per liter). Frozen stocks were maintained at 80°C in 20%
glycerol and 80% MTSB. Biofilms were cultured in 96-well microtiter plates with
glass bottoms (P96G-1.5-5-F; MatTek Corp.) to enable confocal laser scanning
microscope (CLSM) images to be acquired. The biofilm inoculum was prepared
by looping single colonies, cultured on solid medium at 37°C in 5% CO2 for 72 h,
into a 1-ml aliquot of liquid medium and dispersing the suspension of cell
aggregates by repeated pipetting followed by vortexing and finally diluting the
suspension to obtain approximately 107 CFU/ml. No attempt was made to isolate
single cells from cell aggregates as described by Kaplan et al. (27). Biofilms were
cultured at 37°C in 5% CO2. Medium was replaced at 24 h for biofilms cultured
for 48 h.
Antibody. Monoclonal antibody (Aa-MAb) 225AA2 (18) against A. actinomy-
cetemcomitans, isotype mIgG2b, was purified by affinity chromatography on an
AffinityPak protein A column (Thermo Fisher Scientific), following the manu-
facturer’s recommendations with slight modifications. The wash buffer was Dul-
becco’s phosphate-buffered saline (PBS), pH 8.2, and the elution buffers were 0.1
M sodium citrate at pH 5.0, 4.0, and 3.0. Fractions eluted from the column were
concentrated to an optical density at 280 nm (OD280) of approximately 0.2 and
dialyzed into 50 mM HEPES (150 mM NaCl, pH 7.0). Purity of Aa-MAb was
confirmed by SDS-PAGE under reducing conditions to separate the light and
heavy chains. Aa-MAb was biotinylated by reaction for 1 h at room temperature
with 0.5 mM succinimidyl ester of biotin incorporating a hydrophilic spacer
(product no. 21362, EZ-Link NHS-PEG4-biotin; Thermo Scientific Pierce). Un-
reacted reagent was separated from the Aa-MAb by using a Bio-Rad spin
column (equilibrated in 10 mM Tris, pH 7.4). Immunodot blots were used to
confirm the association of the biotin with Aa-MAb and to check the integrity of
the epitope binding site. The covalent addition of the biotin reagent to the light
chain of the Aa-MAb was further confirmed by liquid chromatography-electro-
spray mass spectrometry (LC/MS) as described previously (41). Only the light
chain (biotinylated or nonbiotinylated) could be detected with LC/MS.
The Aa-MAb 225AA2 epitope has not been characterized at the molecular
level. However, its specificity has been characterized (18). The Aa-MAb 225AA2
bound to every A. actinomycetemcomitans strain tested (18 strains with five
different serotypes) and was negative for all non-A. actinomycetemcomitans
strains tested, consisting of 55 species known to be prominent in the oral cavity
(17 genera).
LiDps mutagenesis and expression. Addition of residues KLFC to the C
termini of wild-type LiDps subunits was accomplished by a modification of the
QuikChange site-directed mutagenesis (Stratagene) by using primers containing
extra nucleotides and pET-30b-based plasmids containing the wild-type LiDps
sequence as a template. Primers for mutagenesis contained the nucleotide for the
KLFC tetrapeptide (forward primer, 5-AAGGATCCGAATTCGAGCTCCGT
CGAC-3; reverse primer, 5-AAGGATCCTTAGCAGAATAGCTTTTCTAA
GGAGCTTTTCC-3). The amplified DNAs were transformed into competent
Escherichia coli strain BL21(DE3) (Novagen). For expression and purification of
the assembled KLFC LiDps, cultures of the transformed cells were grown over-
night at 37°C in 30 mg/ml LB-kanamycin. Protein expression was induced with
1.0 mM isopropyl--D-thiogalactopyranoside for 5 h. Cells were pelleted at
3,700  g and resuspended in 50 mM MES (morpholineethanesulfonic acid, pH
6.5; 100 mM NaCl) with lysozyme (50 mg/ml), RNase (90 mg/ml), and DNase (60
mg/ml). A sequence of sonication and French press treatment was used to lyse
cells. Cell fragments were removed by centrifugation at 12,000  g, and the
supernatant was heated to 65°C for 10 min. The suspension was centrifuged at
12,000  g to remove the aggregated heat-sensitive proteins. Assembled KLFC
LiDps was further purified by size exclusion chromatography (SEC) (Superose 6;
Amersham Biosciences, Uppsala, Sweden). The identity and purity of the KLFC
LiDps protein were confirmed by LC/MS, SDS-PAGE, and transmission electron
microscopy (TEM).
Functionalization of the KLFC LiDps. Purified KLFC LiDps was biotinylated
by reaction of 2 mg/ml protein (0.1 mM protein subunit) with 2 mM maleimide
polyethylene glycol (PEG) 2 biotin (product no. 21901; EZ-link; Pierce) for 3 h
at room temperature in MES buffer (pH 6.5; 100 mM NaCl). KLFC LiDps
incorporates no cysteine residues except for those added genetically, and male-
imides react specifically with cysteines of proteins (23). Assembled dodecamer
was purified from the reaction mixture by SEC. Covalent addition of biotin to the
protein subunits was confirmed using LC/MS. For transport studies, fluorescein
was added to the cysteines of the KLFC tetrapeptide by using the same protocol
but with fluorescein-5 maleimide reagent (Invitrogen). A fluorescent tag (Alexa
Fluor 488; Invitrogen) or the photosensitizer (Sn[IV] chlorin e6; Frontier Sci-
entific, Logan, UT) was added to lysines of biotinylated LiDps by reaction with
succinimidyl esters. The succinimidyl ester of Alexa Fluor 488 was purchased
(A20000; Invitrogen). Carboxylate groups of the succinimidyl ester of the SnCe6
were converted to succinimidyl esters by using a modification of a previously
published protocol (10). Sn(IV) chlorin e6 (7 mg), 1-(3-[dimethylamino]propyl)-
3-ethylcarbodiimide hydroxychloride (3 mg), and N-hydroxysuccinimide (4 mg)
were combined in a flame-dried glass anaerobe jar which was placed in an
anaerobe chamber. To this was added 1 ml of dimethylformamide (dry; stored
under nitrogen), the jar was sealed, and the mixture was allowed to react for
approximately 12 h with mixing. The reaction mixture was aliquoted into 50-l
portions, flash frozen in liquid nitrogen, and lyophilized. The succinimidyl esters
of the Alexa Fluor 488 or SnCe6 were added to the biotinylated KLFC LiDps by
reaction of 1 mg/ml protein (0.05 mM protein subunit) with 0.5 mM the reagent
for 3 h at room temperature in 50 mM phosphate buffer (pH 7.5; 100 mM NaCl).
The latter reaction was performed anaerobically in the dark. Prior to addition of
the SnCe6 succinimidyl ester, nitrogen gas was bubbled through the protein
solution for 10 min. The solution was then transferred immediately into an
anaerobe chamber, the reagent was added, and the mixture was covered with foil
and mixed. KLFC LiDps fluorescently tagged or labeled with SnCe6 was purified
by SEC as described above. According to spectrophotometric determination, the
ratios of labeling of the Alexa Fluor 488 and SnCe6 were both approximately
four per dodecamer of LiDps. Extensive dialysis did not decrease these ratios.
We further measured the extent of nonspecific binding of SnCe6 to the dodec-
amer. Dodecamer was exposed to SnCe6 under conditions identical to those
used for reaction with the succinimidyl ester of SnCe6. In this case, comigration
of the absorbance originating from SnCe6 with the dodecamer was negligible.
Transport and targeting of the KLFC LiDps. Transport of dodecamer into A.
actinomycetemcomitans biofilm microcolonies and targeting of dodecamer to the
microcolonies were characterized using SLCM (Leica TCS-SP2-AOBS). Biofilm
microcolonies were visualized through the glass coverslip floor of the wells. This
was accomplished by filling each well to the brim, covering the row of wells with
Parafilm, and inverting the plate. Images were collected with either a 40 0.8 NA
or a 63 0.9 NA HCX APO L U-V-I water immersion objective. Green and red
fluorophores were discriminated by acousto-optical tunable filters. Green flu-
orophores (fluorescein, Syto 9 [Invitrogen], and Alexa Fluor 488) were excited
with a 488-nm laser, and fluorescence was collected from 500 nm to 543 nm. Red
fluorophores (Syto 59 [Invitrogen] and propidium iodide [Sigma-Aldrich]) were
excited with a 561-nm laser, and fluorescence was collected from 600 nm to 721
nm. Images were taken at 1.0-m intervals throughout the depth of the biofilms.
Stacks were combined in Imaris software (Bitplane AG, Zu¨rich, Switzerland) to
yield final images. Transport was evaluated by exposing the biofilm to 1 mg/ml
KLFC LiDps labeled with fluorescein and then tracking changes in the fluores-
cence at the base of the biofilm. Biofilm microcolonies were prestained with Syto
59 for this study so that biofilm microcolonies could be located and brought into
approximate focus, which required about 3 min after filling the well with the
protein solution. Images of the biofilm were acquired at approximately 4-min
intervals by repeating the scan using the same parameters. The fluorescence
increase in areas at the base of microcolonies was assessed as mean pixel bright-
ness by using Adobe Photoshop (v7.0). The colonies stained heavily with the Syto
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59 nucleic acid stain, resulting in strong red fluorescence and slight bleed-
through into the green channel. The corresponding pixel brightness of this
bleed-through was treated as background which was subtracted from the raw
data values. Targeting was performed by exposing biofilms to a series of solutions
in the wells. Biofilms were first washed with 1% bovine serum albumin (BSA) in
10 mM PBS (pH 7.0; 100 mM NaCl) for 5 min. Biofilms were rinsed with PBS
after each reaction. Solutions and exposure times were as follows: biotinylated
Aa-MAb at approximately 50 g/ml for 50 min, streptavidin at 50 g/ml for 30
min, and KLFC LiDps at 100 g/ml for 50 min. The last two steps were repeated
to amplify the level of SnCe6-targeted delivery.
Light exposure. SnCe6 was excited with a 633-nm HeNe laser (Melles Griot,
Carlsbad, CA) defocused with a microscope ocular lens. For light exposure, the
plate was inverted as described above. The plate was placed at a specified
distance from the objective so that the area of the beam was slightly larger than
the area of the floor of the well. Irradiance (W cm2) was determined using a
photometer. The total fluence (J cm2) was determined by the product of the
irradiance and the exposure time. The illumination time was 20 min (1,200 s) to
achieve a total fluence of 14 J cm2, which is in the standard range for antimi-
crobial PDT (25).
Viability assay. Membrane integrity of A. actinomycetemcomitans cells in bio-
film microcolonies was evaluated using the BacLight Live/Dead bacterial viability
assay (Molecular Probes) (28). Saline solutions of Syto 9 and propidium iodide
at concentrations recommended by the manufacturer of the kit (L-7012; Molec-
ular Probes) were used. Propidium iodide (red) penetrates cells with compro-
mised membranes, while Syto 9 (green) penetrates all cells. Photomultiplier tube
(PMT) sensitivity for the red and green channels was optimized so that signal was
well above background while minimizing bleed-through. These optimized set-
tings were used for each experiment. The red/green ratio was quantified as the
ratio of pixel intensities of the red and green channels evaluated using Meta-
Morph software (Molecular Devices Corporation, Downingtown, PA). Micro-
colonies were selected for analysis, excluding dark regions between the colonies.
This was accomplished by “thresholding.” Histograms of number of pixels versus
pixel brightness were constructed and then truncated to omit the dark inter-
colony regions. Mean pixel brightness of the associated truncated histograms was
then calculated. The relationship between the red/green ratio and membrane
disruption was assessed by using the red/green ratio induced in biofilms exposed
to 0.1 mg/ml chlorhexidine digluconate (CHG) for 1 h as an internal standard for
each experiment. In preliminary studies, we determined that exposure of cell
suspensions of A. actinomycetemcomitans used for biofilm inocula to 0.1 mg/ml
CHG for 1 h reduces the number of CFU by 3 orders of magnitude. (The rough
colony A. actinomycetemcomitans variant remains primarily in cell aggregates
even when dispersed into liquid).
Statistical analysis. Efficacy of the targeted SnCe6 was evaluated by a paired
t test. Three independent replicates were performed on separate days. Each
experiment included three or four untreated biofilms with the wells for these
biofilms distributed along a row of 10 wells. Two targeted biofilms exposed to
light as well as one well with a nontargeted biofilm exposed to light were also
included in each experiment. These wells were located toward one side of the
row to minimize the effect of scattered laser light on unexposed wells. Red/green
ratios were normalized to the red/green ratio obtained for internal standard (the
0.1 mg/ml CHG condition). Means of within-experiment replicates were used for
the paired t test.
RESULTS
Transport of LiDps into A. actinomycetemcomitans biofilm
microcolonies. Transport of KLFC LiDps into A. actinomyce-
temcomitans microcolonies was characterized using SLCM.
The absence of targeting allowed transport kinetics to be mea-
sured without the additional factor of binding kinetics. The
well was filled with a solution of KLFC LiDps, fluorescently
tagged via the peptidyl cysteine residues, and the time course
of increase in fluorescence was measured at locations at the
base of microcolonies (near the substratum) and in the interior
of microcolonies with respect to the view in the plane of the
substratum. The A. actinomycetemcomitans biofilm was stained
with a red nucleic acid stain prior to the transport study (Fig.
1A). Figure 1B shows the mean kinetics of transport of the
fluorescently tagged KLFC LiDps to locations at the base of 16
A. actinomycetemcomitans microcolonies. Figure 1B indicates
that the mean concentration of dodecamer in the interior re-
gions of A. actinomycetemcomitans microcolonies reached a
level of approximately 60% of the fluorescent signal in the bulk
(between microcolonies) at 20 min.
Figures 1C and D are SLCM images taken at a section
proximal to the substratum interface 5 and 20 min, respec-
tively, after exposure of the biofilm to the fluorescently tagged
KLFC LiDps. Locations where data were acquired to construct
Fig. 1B are indicated. There was a 20% increase in the fluo-
rescence signal from the bulk solution (between the microcolo-
nies) between the first and second time points (4 and 8 min,
respectively), which then remained constant. This is likely due
to diffusion of the multimeric protein into a static boundary
layer near the substratum, accompanied, perhaps, by nonspe-
cific adsorption onto the substratum. The 100% value for flu-
orescence was taken as the value for the later times points in
order to construct the data presented in Fig. 1B. One possible
reason for the exclusion of fluorescence from peripheral re-
gions of the microcolonies may be that there is a greater
density of extracellular matrix in these regions. However, we
have no direct evidence for this.
Dual-functionalized LiDps for targeting. The 12 terminating
cysteines (C) on the tetrapeptides of the KLFC LiDps con-
struct provide ideal attachment sites for targeting moieties
since they are displaced from the exterior dodecamer shell (21)
by the peptide spacer (KLFC). The biotinylation reagent pro-
vides a further extension of the spacer length (3 nm) between
the biotin and the dodecamer external surface. The covalent
addition of one biotin maleimide functional group to each of
the monomeric subunits was confirmed using LC/MS (Fig. 2A
and B). Some oxidation of the biotinylated product is indicated
by the appearance of small higher-molecular-mass bands
spaced 16 Da apart (26).
Biotinylated KLFC LiDps (KLFC-LiDps-B) was further
functionalized with either Alexa Fluor 488 (KLFC-LiDps-B-
AF) or SnCe6 (KLFC-LiDps-B-SnCe6). KLFC-LiDps-B-AF is
an analog of the KLFC-LiDps-B-SnCe6 with Alexa Fluor 488
substituted for SnCe6. Succinimidyl esters of these compounds
were added to intrinsic lysines of the dodecamer. Association
of these functionalities with the dodecamer was confirmed by
comigration of a distinguishing absorbance band of the Alexa
Fluor 488 or SnCe6 with the dodecamer on SEC (Fig. 2C and
D). Extensive dialysis did not reduce the ratio of the functional
group to protein (determined spectrophotometrically), indicat-
ing that the functional groups were covalently bound to the
lysines.
Targeting of A. actinomycetemcomitans biofilm microcolonies
with LiDps. KLFC-LiDps-B-AF was used to characterize tar-
geting of A. actinomycetemcomitans biofilm since SnCe6 fluo-
rescence was not in an appropriate range for SLCM detection.
The targeting approach used for both KLFC-LiDps-B-AF and
KLFC-LiDps-B-SnCe6 is illustrated in Fig. 3A. Streptavidin
was used to couple KLFC-LiDps-B-AF to biotinylated Aa-
MAb bound to the biofilm cells. The loading of the fluoro-
phore per Aa-MAb epitope binding site was subsequently in-
creased by repeating cycles of exposure to streptavidin and
biotinylated dodecamer, with a consequent amplification in
fluorescence signal. The first row of SLCM images in Fig. 3B
(panels i, ii, and iii) are 48-h A. actinomycetemcomitans bio-
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films targeted with KLFC-LiDps-B-AF. The mean fluores-
cence within 48-h A. actinomycetemcomitans biofilm micro-
colonies was increased by factors of 3.4 and 6.3 for one and two
repeated cycles of exposure to streptavidin and KLFC-LiDps-
B-AF, respectively (Fig. 3B, panels ii and iii). Binding to A.
actinomycetemcomitans microcolonies was primarily mediated
through the specific Aa-MAb/epitope interaction, as indicated
by the much lower fluorescent signal acquired when the Aa-
MAb was omitted from the series of reactions (Fig. 3C, panels
i, ii, and iii). There was a slight amount of nonspecific binding
of the dodecamer to the A. actinomycetemcomitans biofilm
microcolonies, indicated by a fluorescent signal in the green
channel which was above background and which was also am-
plified by cycles of exposure to streptavidin and KLFC-LiDps-
B-AF. The KLFC-LiDps-B-AF fluorescence within microcolo-
nies was lower by factors of 248, 802, and 8 (Fig. 3B and C,
from left to right, respectively) when Aa-MAb was omitted
from the reaction.
Images of sections in the plane of the interface and sections
taken perpendicular to the interface both indicated that the
fluorescence distribution in the microcolonies was nonuniform
for 48-h biofilms targeted with dodecamer, with a denser con-
centration of fluorescence near the peripheries of microcolo-
nies. In contrast, the fluorescence originating from nonspecific
interactions (Fig. 3C) was uniformly distributed throughout
the A. actinomycetemcomitans colonies. This is more evident if
the images are contrast enhanced (data not shown). This result
suggests that the distribution of fluorescence in targeted A.
actinomycetemcomitans microcolonies reflects the Aa-MAb
epitope distribution in 48-h A. actinomycetemcomitans micro-
colonies, rather than originating from hindered transport (con-
sistent with the transport study).
In contrast with 48-h targeted biofilms, 24-h targeted bio-
films show a more even uniform distribution of KLFC-LiDps-
B-AF (Fig. 3D, E, and F). The brightness/contrast of these
images was optimized (identically) to show the pattern of flu-
orescence. Figure 3E shows a magnified view of a microcolony.
A comparison of the pixel brightness levels within the two
squares showed that even fluorescence within the darkest re-
gion of a large microcolony was twice that of the background.
Figure 3F shows the level of nonspecific binding of the KLFC-
LiDps-B-AF to the A. actinomycetemcomitans microcolonies
when the Aa-MAb was omitted.
Light-induced membrane disruption of SnCe6-targeted A.
actinomycetemcomitans biofilm. The red/green ratio deter-
mined from the viability assay upon exposure of biofilms to 0.1
mg/ml CHG for 1 h was used as an internal standard for
assessing the efficacy of light-induced membrane disruption of
FIG. 1. Transport of fluorescently tagged KLFC LiDps into A. actinomycetemcomitans biofilm microcolonies. (A) Biofilm microcolonies stained
with Syto 59 (4.167-m tick spacing). Microcolonies circled with the dashed lines are the same ones circled in panel C. (B) Transport kinetics of
fluorescently tagged KLFC Dps into regions at the base of biofilm microcolonies. The solid line connects data which are the means of
measurements at 16 locations; error bars represent the standard deviations. (C) Section acquired near the substratum 4 min after exposure of the
biofilm to the fluorescently tagged KLFC LiDps; regions used to acquire the data presented in panel B are indicated. (D) Section acquired near
the substratum 21 min after exposure of the biofilm to the fluorescently tagged KLFC LiDps.
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SnCe6-targeted cells. The rationale for this was that CHG has
been shown previously to be efficacious against A. actinomyce-
temcomitans biofilms (48), and the primary mode of action of
CHG is membrane disruption (24). According to the viability
assay, there was a clear breakpoint between 0.1 mg/ml CHG
and 0.01 mg/ml CHG (see Fig. S1 in the supplemental mate-
rial). A. actinomycetemcomitans biofilms exposed to these two
CHG concentrations for 1 h were included in each experiment
as internal standards.
A. actinomycetemcomitans biofilms were targeted with KLFC-
LiDps-B-SnCe6 by using the same protocol as that for KLFC-
LiDps-B-AF (Fig. 3A). In a preliminary experiment, we ob-
tained no evidence of membrane disruption of 48-h biofilms.
We proceeded to test 24-h biofilms and obtained evidence of
membrane disruption for biofilms targeted using two cycles of
exposure to streptavidin followed by KLFC-LiDps-B-SnCe6.
We attempted to gather data demonstrating a correlation be-
tween loss of viability and cycles of amplification by using the
KLFC-LiDps-B-SnCe6 construct, but the variability was too
great to make any strong claims. As indicated in Fig. 4, mem-
brane disruption induced by exposure of SnCe6-targeted A.
actinomycetemcomitans microcolonies to light (Fig. 4B) was
intermediate between that of untreated microcolonies (Fig.
4A) and that of microcolonies exposed to 0.1 mg/ml CHG (Fig.
4C). The mean red/green ratio for SnCe6-targeted microcolo-
nies exposed to light compared to those exposed to 0.1 mg/ml
CHG was 0.62 (standard deviation [SD] of 0.21) for three
independent experiments. The red/green ratio for the SnCe6-
targeted microcolonies exposed to light was higher than those
for both untreated microcolonies and SnCe6-targeted micro-
colonies not exposed to light at the 5% level of confidence
(Table 1). The red/green ratio for the SnCe6-targeted micro-
colonies exposed to light was higher than those for both mi-
crocolonies exposed to light but not targeted with SnCe6 and
microcolonies exposed to 0.01 mg/ml CHG at the 10% level of
confidence (Table 1). Data for all three experiments are shown
in the supplemental material (see Fig. S2).
DISCUSSION
Our results indicate that the KLFC LiDps can be trans-
ported into A. actinomycetemcomitans microcolonies during a
reasonable time period, that cells within the microcolonies can be
targeted with the dodecamer, and that this multimeric protein can
be used as a vehicle for targeted delivery of a photosensitizer to A.
actinomycetemcomitans microcolonies. The susceptibility of A. ac-
tinomycetemcomitans biofilms to antimicrobials has been shown
to decrease as the biofilm matures (45). Consistent with these
results, we observed no light-induced decrease in the viability
of 48-h biofilms targeted with photosensitizer, while there was
clear evidence of light-induced membrane disruption of 24-h
biofilms targeted with a photosensitizer. The more uniform
Aa-MAb epitope distribution in 24-h A. actinomycetemcomi-
tans microcolonies may have been partially responsible for this
result (Fig. 3). In general, mechanical plaque removal is not
sufficient to completely eliminate oral biofilm (2), and this has
been shown to be the case for A. actinomycetemcomitans (34).
Selective killing of A. actinomycetemcomitans early-stage bio-
films would presumably enhance the ability of commensals to
compete with A. actinomycetemcomitans during recolonization
FIG. 2. Dual-functionalized KLFC LiDps. (A and B) LC/MS deconvolutions of mass spectra of monomeric subunits of the dodecamer.
(A) Mass of nonfunctionalized KLFC LiDps monomeric subunits (18,540 Da). (B) Mass of biotinylated KLFC LiDps (KLFC-LiDps-B) monomeric
subunits (19,065 Da). The difference in mass between the subunits in panels A and B (525 Da) is expected for addition of the biotinylation reagent
to the cysteines. The deconvolved spectrum in panel B indicates that all the 12 subunits of KLFC LiDps were biotinylated. (C and D) Size exclusion
chromatograms of biotinylated KLFC LiDps tagged with Alexa Fluor 488 (KLFC-LiDps-B-AF) (C) or functionalized with the SnCe6 (KLFC-
LiDps-B-photosensitizer) (D). The solid lines represent the absorbance at 280 nm (protein). The dashed lines indicate the absorbances of the Alexa
Fluor 488 (488 nm) or photosensitizer (410 nm) (C and D, respectively). The vertical straight line indicates the position at which the dodecamer
elutes.
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(47), thus conferring a measure of colonization resistance to
periodontal tissues (33). In addition, the recolonization by a
consortium in which commensals were predominant might aid
in establishing a healthy immune balance at diseased sites, allow-
ing periodontal tissues more leverage to eliminate intracellular
(invasive) A. actinomycetemcomitans.
Transport of macromolecules through a polymicrobial oral
biofilm was found previously to be significantly hindered (49).
The shape of the data curves presented in Fig. 1B suggests that
the LiDps dodecamer attained about 90% saturation in central
regions at the base of the A. actinomycetemcomitans biofilm
microcolonies at 20 min. The fluorescence in these regions at
20 min was about 35 to 95% of the fluorescence in the bulk,
with a mean of about 60%. An extensive review of the litera-
ture indicated that the diffusion coefficient of macromolecules
the size of the LiDps (molecular mass, 222 kDa) could be
reduced in biofilms by as much as a factor of about 0.02
compared to the diffusion coefficient in water (39). This trans-
FIG. 3. Targeting of A. actinomycetemcomitans biofilm microcolonies with KLFC-LiDps-B-AF. (A) Illustration of presumed cluster formation
produced by cycles of exposure to streptavidin followed by KLFC-LiDps-B-AF, resulting in an amplification of the fluorescent signal at sites of
Aa-MAb binding. Ab, Aa-MAb; StAv, streptavidin; Dps, KLFC Dps; CWE, cell wall epitope. (B) Forty-eight-hour biofilm microcolonies targeted
with biotinylated KLFC Dps tagged with Alexa Fluor 488 for one to three cycles of exposure to streptavidin followed by KLFC-LiDps-B-AF. One
cycle means exposure to Aa-MAb followed by streptavidin followed by KLFC Dps. (i) One cycle. (ii) Two cycles. (iii) Three cycles. (C) Biofilms
treated the same as described for panel B except that the Aa-MAb was omitted from the first step. (D) Twenty-four-hour biofilm targeted with
biotinylated KLFC Dps tagged with Alexa Fluor 488. (E) Magnified view of a selected portion of panel D, showing the relatively even distribution
of fluorescence from the targeted dodecamer; pixel brightness computed for two small regions indicated that even the darkest region of the
microcolonies was twice as fluorescent as the background (small squares). (F) Biofilm was treated the same as described for panel D but the
Aa-MAb was omitted.
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lates to about 17 min to reach 90% saturation in a 30-m-thick
planar slab, indicating that the transport kinetics of the LiDps
dodecamer that we measured are consistent with previous
studies. In terms of eventual clinical application, the mean
fluorescence at 5 min in locations that were relatively inacces-
sible was approximately 25% of the bulk fluorescence. Esti-
mating the volume excluded by the cells to be 50%, the inter-
cellular concentration at 5 min in the interior portions of the
biofilm was about 50% of the bulk concentration. This may be
sufficient to effectively target A. actinomycetemcomitans bio-
films during a 5-min exposure period if the affinity coefficient
for binding of the targeting moieties is sufficiently high.
Advantages of the targeting approach we used in this study
include modularity and ability to amplify the loading. The mod-
ularity of the system allows different targeting moieties to be
combined easily with a single functionalized multimeric protein.
We have shown previously that loading of a small molecule onto
a 12-nm, 24-subunit small heat shock protein from Methanococ-
cus jannaschii can be increased substantially by incorporating a
polymer confined to the interior cavity delineated by the protein
shell (1). Although the nucleation and stepwise growth required
to synthesize the polymer are fairly sophisticated, the process can
be streamlined to produce large quantities of the biotinylated
product. Recently, we synthesized an asymmetrically biotinylated
LiDps dodecamer that enables one-step targeting via an antibody
while preserving the modular design (42). Another advantage of
our targeting approach is the possibility of increasing the loading
with a sequence of applications. Previously, we characterized sig-
nal amplification that can be obtained by exploiting the strepta-
vidin/biotin interaction to obtain clusters of the cowpea chlorotic
mottle virus (CCMV) capsule bound at nucleation sites (40). We
acquired atomic force microscopy (AFM) images to confirm for-
mation of CCMV clusters at a planar interface (43). Here, we
used a similar approach to increase the photosensitizer loading at
targeted sites. Although the amplification in the fluorescence
signal shown in Fig. 3B suggests that aggregated clusters of the
dodecamer are forming at sites of Aa-MAb binding as depicted in
Fig. 3A, we have no direct evidence to support this interpretation.
With respect to clinical relevance, topical application of a se-
quence of agents may be feasible if the application time is within
5 min. However, for some applications, it will obviously be desir-
able to have a one-step administration.
The antimicrobial action of photosensitizers against Gram-
negative bacteria is known to be less than that against Gram-
positive bacteria (19, 25). One method to enhance photosen-
sitizer action against Gram-negative bacteria is to couple the
photosensitizer to a cationic peptide or polymer (20, 46). This
enhancement may originate from the localized concentration
of photosensitizer near the cell membrane or, alternatively,
from disruption of the membrane by the cationic moieties. The
former explanation is consistent with the loss of viability we
observed for cells targeted with photosensitizer and exposed to
light. We cannot claim that cells in biofilms were in fact killed,
since we have no direct evidence for this. However, our results
indicate that membranes of photosensitizer-targeted cells ex-
posed to light were more permeable than were controls, and thus,
these cells may be sufficiently damaged to substantially decrease
their competitiveness when growing in a developing oral consor-
tium.
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